Published in Eur J Cardiovasc Prev Rehabil on August 01, 2003
A marketing perspective on disseminating evidence-based approaches to disease prevention and health promotion. Prev Chronic Dis (2006) 2.51
Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial. Br J Gen Pract (2010) 2.42
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J (2011) 2.29
Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev (2004) 2.05
Association of Empirically Derived Dietary Patterns with Cardiovascular Risk Factors: A Comparison of PCA and RRR Methods. PLoS One (2016) 1.97
Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2010) 1.71
The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J (2009) 1.48
Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk? Eur J Clin Pharmacol (2005) 1.42
Dyslipidemic drugs in metabolic syndrome. Indian J Endocrinol Metab (2013) 1.39
The influence of hospitalisation on drug prescription in primary care--a large-scale follow-up study. Eur J Clin Pharmacol (2007) 1.37
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk. PLoS One (2011) 1.34
Modifiable cardiovascular risk factors among apparently healthy adult Nigerian population - a cross sectional study. BMC Res Notes (2010) 1.22
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial. Heart (2013) 1.17
Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol (2008) 1.14
Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach. Neth Heart J (2012) 1.13
Healthy hearts--a community-based primary prevention programme to reduce coronary heart disease. BMC Cardiovasc Disord (2008) 1.08
Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study. Nutr Metab Cardiovasc Dis (2009) 1.08
Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial. BMJ (2012) 1.07
The (cost-)effectiveness of an individually tailored long-term worksite health promotion programme on physical activity and nutrition: design of a pragmatic cluster randomised controlled trial. BMC Public Health (2007) 1.04
The impact of 3-year changes in lifestyle habits on metabolic syndrome parameters: the D.E.S.I.R study. Eur J Cardiovasc Prev Rehabil (2006) 1.02
Prevalence and determinants of electrocardiographic abnormalities in African Americans with type 2 diabetes. J Epidemiol Glob Health (2014) 0.95
Gender-specific association of psychological distress with cardiovascular risk scores. Scand J Prim Health Care (2010) 0.95
Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study. Cardiovasc Diabetol (2005) 0.95
The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13). PLoS One (2009) 0.92
Effects of expanded cardiac rehabilitation on psychosocial status in coronary artery disease with focus on type D characteristics. J Behav Med (2007) 0.92
Cardiovascular risk assessment of Bulgarian urban population: cross-sectional study. Croat Med J (2008) 0.91
Nutrition, environment and cardiovascular health (NESCAV): protocol of an inter-regional cross-sectional study. BMC Public Health (2010) 0.91
VTE Risk assessment - a prognostic Model: BATER Cohort Study of young women. Thromb J (2005) 0.89
Can individuals with a significant risk for cardiovascular disease be adequately identified by combination of several risk factors? Modelling study based on the Norwegian HUNT 2 population. J Eval Clin Pract (2009) 0.88
Prevalence of ischemic heart disease among urban population of siliguri, west bengal. Indian J Community Med (2009) 0.87
Does analgesic effect of opium hamper the adverse effects of severe coronary artery disease on quality of life in addicted patients? Anesth Pain Med (2012) 0.87
Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden. Eur J Clin Pharmacol (2008) 0.86
Classical risk factors of cardiovascular disease among Chinese male steel workers: a prospective cohort study for 20 years. BMC Public Health (2011) 0.85
Cardiopulmonary exercise testing, prehabilitation, and Enhanced Recovery After Surgery (ERAS). Can J Anaesth (2015) 0.85
Peripheral arterial disease and ankle-brachial pressure index as predictors of mortality in residents of Metlika County, Slovenia. Croat Med J (2006) 0.84
Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study. Eur J Cardiovasc Prev Rehabil (2010) 0.84
Prognostic significance of serial Q/ST-T changes by the Minnesota Code and Novacode in the Atherosclerosis Risk in Communities (ARIC) study. Eur J Prev Cardiol (2011) 0.83
Correlation of blood pressure, obesity, and adherence to the Mediterranean diet with indices of arterial stiffness in children. Eur J Pediatr (2012) 0.83
Impact of health counselling on cardiovascular disease risk in middle aged men: influence of socioeconomic status. PLoS One (2014) 0.83
[Cardiovascular secondary prevention]. Clin Res Cardiol (2006) 0.82
Effects of Tai Chi on adiponectin and glucose homeostasis in individuals with cardiovascular risk factors. Eur J Appl Physiol (2010) 0.82
All-cause mortality and mortality of myocardial infarction for 989 legally castrated men. Eur J Epidemiol (2005) 0.82
Perceived psychosocial stress and cardiovascular risk factors in obese and non-obese patients. Clin Res Cardiol (2007) 0.82
Clinical and scientific progress related to the interface between cardiology and psychology: lessons learned from 35 years of experience at the Thoraxcenter of the Erasmus Medical Center in Rotterdam. Neth Heart J (2011) 0.81
Randomized controlled trial on the long-term efficacy of a multifaceted, interdisciplinary lifestyle intervention in reducing cardiovascular risk and improving lifestyle in patients at risk of cardiovascular disease. J Behav Med (2012) 0.81
Observational study of lipid profile and LDL particle size in patients with metabolic syndrome. Lipids Health Dis (2011) 0.81
Cross-sectional epidemiological study to evaluate the cardiovascular profile of a cohort of blood donors. Blood Transfus (2007) 0.81
Coronary artery calcium and primary prevention risk assessment: what is the evidence? An updated meta-analysis on patient and physician behavior. Circ Cardiovasc Qual Outcomes (2012) 0.81
Higher prevalence of smoking and lower BMI, waist circumference, cholesterol and triacylglyceride levels in Prague's homeless compared to a majority of the Czech population. BMC Public Health (2007) 0.80
"Obesity paradox" in coronary artery disease. World J Cardiol (2015) 0.80
Ten-Year Survival in 75-Year-Old Men and Women: Predictive Ability of Total Cholesterol, HDL-C, and LDL-C. Curr Gerontol Geriatr Res (2009) 0.80
Relation between awareness of circulatory disorders and smoking in a general population health examination. BMC Public Health (2006) 0.80
Mixed dyslipidemias in primary care patients in France. Vasc Health Risk Manag (2012) 0.79
Low-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: data from the Chinese Longitudinal Healthy Longevity Survey. Atherosclerosis (2015) 0.79
The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers. BMC Pulm Med (2014) 0.78
Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study. Vasc Health Risk Manag (2007) 0.78
Measurement of coronary calcium scores or exercise testing as initial screening tool in asymptomatic subjects with ST-T changes on the resting ECG: an evaluation study. BMC Cardiovasc Disord (2007) 0.78
The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial. BMC Cardiovasc Disord (2012) 0.78
Cardiovascular risk tables. BMJ (2008) 0.77
Prevalence dependent calibration of a predictive model for nasal carriage of methicillin-resistant Staphylococcus aureus. BMC Infect Dis (2013) 0.77
[Primary prevention-psychosocial aspects]. Z Kardiol (2005) 0.77
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study. PLoS One (2016) 0.77
Single and mixed dyslipidaemia in Canadian primary care settings: findings from the Canadian primary care sentinel surveillance network database. BMJ Open (2015) 0.77
Screening families of patients with premature coronary heart disease to identify avoidable cardiovascular risk: a cross-sectional study of family members and a general population comparison group. BMC Res Notes (2010) 0.77
Rationale for multiple risk intervention: the need to move from theory to practice. Vasc Health Risk Manag (2007) 0.77
Risk factors for contrast induced nephropathy: a study among Italian patients. Indian Heart J (2012) 0.76
Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness. Arthritis Res Ther (2010) 0.76
Atypical presentation of acute and chronic coronary artery disease in diabetics. World J Cardiol (2014) 0.76
Role of computed tomography in risk assessment for coronary heart disease. Postgrad Med J (2006) 0.76
Behavioral interventions for coronary heart disease patients. Biopsychosoc Med (2012) 0.76
[Value of coronary artery calcium measurements in primary prevention]. Z Kardiol (2005) 0.76
Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity. Funct Neurol (2014) 0.75
Prevalence of Cardiovascular Risk Factors among Tile and Ceramic Workers in Yazd, Iran. ISRN Prev Med (2013) 0.75
Prevalence and management of cardiovascular risk factors in Portuguese living in Portugal and Portuguese who migrated to Switzerland. BMC Public Health (2015) 0.75
A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk. Ther Clin Risk Manag (2011) 0.75
Novel quercetin-3-O-glucoside eicosapentaenoic acid ester ameliorates inflammation and hyperlipidemia. Inflammopharmacology (2015) 0.75
Parental Age of Onset of Cardiovascular Disease as a Predictor for Offspring Age of Onset of Cardiovascular Disease. PLoS One (2016) 0.75
Post-prandial lipid levels for assessing target goal achievement in type 2 diabetic patients taking statin. J Korean Med Sci (2010) 0.75
Absence of increase in carotid artery intima-media thickness in infants of diabetic mothers. J Clin Res Pediatr Endocrinol (2011) 0.75
Statins for primary prevention: strategic options to save lives and money. J R Soc Med (2004) 0.75
A Multifaceted Nurse- and Web-Based Intervention for Improving Adherence to Treatment in Patients With Cardiovascular Disease: Rationale and Design of the MIRROR Trial. JMIR Res Protoc (2016) 0.75
Impact of a soy drink on climacteric symptoms: an open-label, crossover, randomized clinical trial. Gynecol Endocrinol (2016) 0.75
MediterrAsian Diet Products That Could Raise HDL-Cholesterol: A Systematic Review. Biomed Res Int (2016) 0.75
Coronary artery disease detection using a fuzzy-boosting PSO approach. Comput Intell Neurosci (2014) 0.75
Conflicts between personal and public health care: can one GP serve two masters? Br J Gen Pract (2007) 0.75
Cardiovascular Safety of Oral Antidiabetic Medications: Need of the Hour. Indian J Endocrinol Metab (2017) 0.75
Association of daily physical activity level with health-related factors by gender and age-specific differences among Korean adults based on the sixth (2014-2015) Korea National Health and Nutrition Examination Survey. J Exerc Nutrition Biochem (2017) 0.75
Impact of high dose statin trials on hospital prescribers. Eur J Clin Pharmacol (2006) 0.75
Women and men with unstable angina and/or non-ST-elevation myocardial infarction. Wien Klin Wochenschr (2006) 0.75
Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers. Eur J Clin Pharmacol (2008) 0.75
[ESC/EASD joint guidelines on diabetes and cardiovascular diseases]. Herz (2009) 0.75
[Prevention of arteriosclerosis. Importance of the treatment of arterial hypertension]. Z Kardiol (2005) 0.75
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol (2003) 16.71
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet (2007) 13.28
Many sequence variants affecting diversity of adult human height. Nat Genet (2008) 12.80
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet (2007) 12.65
Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet (2008) 12.43
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA (2005) 12.00
Universal definition of myocardial infarction. Circulation (2007) 11.69
Point: cardiovascular variability is/is not an index of autonomic control of circulation. J Appl Physiol (1985) (2006) 11.52
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J (2011) 10.52
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Guidelines on myocardial revascularization. Eur Heart J (2010) 8.85
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet (2008) 8.63
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J (2003) 8.51
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med (2004) 8.07
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet (2008) 6.72
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet (2004) 6.37
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Where is the evidence that animal research benefits humans? BMJ (2004) 5.99
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet (2007) 5.88